These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6378391)

  • 1. Changes in splenic histology and cytology in mice bearing plasmacytomas.
    Berman JE; Zolla-Pazner S
    Cell Immunol; 1984 Aug; 87(1):137-46. PubMed ID: 6378391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
    Berg DJ; Lynch RG
    J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
    Joshua DE; Humphrey JH; Grennan D; Brown G
    Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of B cell proliferation: inhibition of responses to B cell mitogens induced by plasma cell tumors.
    Berman JE; Zolla-Pazner S
    J Immunol; 1985 May; 134(5):2872-8. PubMed ID: 2580004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the humoral immune response by particulate material extracted from spleen cell subpoulations of MOPC-315 tumor-bearing mice.
    Kleinman R
    Immunol Commun; 1979; 8(2):131-43. PubMed ID: 374242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas.
    Padarathsingh ML; McCoy JL; Dean JH; Lewis DD; Northing JW; Law LW
    J Natl Cancer Inst; 1977 Jun; 58(6):1701-7. PubMed ID: 301196
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
    Berman JE; Zolla-Pazner S
    J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH; Anderson AB
    Cancer Res; 1988 Mar; 48(6):1398-403. PubMed ID: 3257896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
    Kolb JP; Arrian S; Zolla-Pazner S
    J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic immune effector and suppressor cells in mice bearing a growing plasmacytoma.
    Chen YH; Anderson AB; Williams KG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5473-9. PubMed ID: 2932218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immunosuppressive substance in mice bearing plasmacytomas.
    Tanapatchaiyapong P; Zolla S
    Science; 1974 Nov; 186(4165):748-50. PubMed ID: 4547576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in plasmacytoma: induction of suppressor cells.
    Chen Y; Hwang LT; Heller P
    Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G; Ophir R; Pecht M; Ben-Efraim S
    In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by an immunogenic immunomodulating mycobacterial fraction is correlated to changes in phenotype distribution of murine lymphoid cells.
    Rashid G; Halperin D; Zan-Bar I; Ben-Efraim S
    In Vivo; 1991; 5(1):71-8. PubMed ID: 1932631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.